AzTrials
AzTrials

Hypoplastic Left Heart SyndromeNCT00156455

Sleep Disordered Breathing in Children With Single Ventricle Physiology

An observational study of Hypoplastic Left Heart Syndrome and Obstructive Sleep Apnea Syndrome, run by University of Rochester at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This is an exploratory study designed to evaluate the incidence of, and to quantify sleep disordered breathing following stage I Norwood reconstructive surgery. Sleep disordered breathing will be correlated with: 1. Elevations in pulmonary vasculature resistance at the time of Stage II surgery. 2. Risks of death Read more about this study

Who is it for?
Ages 1 month to 2 years
How many people
0 participants
Where
1 siteUnited States
Study dates
Sep 2004to Mar 2008
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 2 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: children with hypoplasic heart condition

Who may be able to join

  • Infants with single ventricle physiology Parents who can read and write English

Who cannot join

  • Infants who are not medically stable Parents who cannot read and write English

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Rochester

    Rochester, New York, 14642

Other trials in United States

About this study

This is an exploratory study designed to evaluate the incidence of, and to quantify sleep disordered breathing following stage I Norwood reconstructive surgery. Sleep disordered breathing will be correlated with:

  1. Elevations in pulmonary vasculature resistance at the time of Stage II surgery.
  2. Risks of death
Read the detailed description

This is an exploratory study designed to evaluate the incidence of, and to quantify sleep disordered breathing following stage I Norwood reconstructive surgery. Sleep disordered breathing will be correlated with:

  1. Elevations in pulmonary vasculature resistance at the time of Stage II surgery.
  2. Risks of death

Children with single ventricle physiology are exquisitely sensitive to alterations in pulmonary vascular resistance. Following their first operative repair (stage I Norwood), performed in their first week of life, pulmonary and systemic circulations are in parallel rather than series. As such, elevations in pulmonary vascular resistance can result in severe arterial desaturation. Additionally, elevated pre-operative pulmonary artery pressure is directly correlated with poor survival following the third and final operative repair (stage III Norwood, or Fontan).

Periodic breathing is a normal breathing pattern in sleeping infants. At the other end of the spectrum is sleep apnea. In between lies a continuum of sleep disordered breathing. Obstructive sleep apnea has an incidence of approximately 2% in children, and is associated with pulmonary and systemic hypertension. Specific studies of the incidence and effects of sleep disordered breathing in congenital heart disease are lacking. Otherwise normal children have baseline oxygen saturation in the high 90's, thereby placing them on the flat part of the oxyhemoglobin curve. But children with cyanotic congenital heart disease live with baseline oxygen saturations in the mid 70's, so that they exist on the steep part of the oxyhemoglobin dissociation curve. We hypothesize therefore that these patients are at increased risk for the hemodynamic variations occurring during apneas/hypopneas even when they are more subtle, namely during sleep disordered breathing.

We hypothesize that children who have completed stage I Norwood will experience more significant arterial desaturations during sleep associated apneic events (due to the concurrent elevation in pulmonary arterial pressure) than their normal counterparts. Additionally we hypothesize that children who experience more frequent apneic events during sleep will have elevated pre-operative pulmonary artery pressures and therefore worse outcome following stage II Norwood. Thus, we speculate that children who have completed stage I Norwood are more prone to the risks of sleep disordered breathing.

Autonomic regulation, mediated in part by aortic arch baroreceptors, is undoubtedly disrupted by the extensive surgical reconstruction required at the aortic arch during stage I Norwood palliation. Adults and children with severe sleep disordered breathing (obstructive sleep apnea) have impaired cardiac autonomic control, and increased cardiac electrical instability, with greater occurrence of ventricular arrhythmias. Apneic events place a hypoxic, mechanical and adrenergic load on the cardiovascular system thereby directly resulting in ventricular dysrhythmias. Observed late deaths following stage I Norwood are usually postulated to be secondary to fatal arrhythmias. Thus, we hypothesize that children who experience more frequent apneic events during sleep will have an increased risk of interstage mortality.

Sleep disordered breathing is a readily treatable condition in the pediatric population. Non-invasive, continuous positive airway pressure applied via a nasal mask is effective in treating sleep disordered breathing in infants. Thus, if sleep disordered breathing is identified, effective treatment is available and may reduce the risk of inter-stage mortality and adverse hemodynamics in this medically fragile population.

Keywords
Children, Hypoplastic left heart syndrome, Obstructive Sleep Apnea Syndrome, Single Ventricle Physiology
Medical subject headings
Hypoplastic Left Heart Syndrome, Sleep Apnea, Obstructive

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2005 (estimated)
  2. Study startSep 2004
  3. Primary completionMar 2008

Why it stopped: lack of study personel

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00156455
Sponsor's protocol ID
10185
Status last verified
Apr 2015
First submitted
8 Sep 2005
Last updated
30 Apr 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hypoplastic Left Heart Syndrome and Obstructive Sleep Apnea Syndrome, run by University of Rochester at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 30 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in